Stockreport

Pharvaris to Present Deucrictibant Clinical Data at Upcoming Congresses [Yahoo! Finance]

Pharvaris N.V. - Ordinary Shares  (PHVS) 
PDF antagonists to treat and prevent hereditary angioedema (HAE) attacks, today announced the acceptance of abstracts for presentation at two upcoming congresses: the 3rd Na [Read more]